chemicell
REFERENCES

References - Biomagnetic Separation

1.01
Bergemann C., Müller-Schulte D., Oster J., Brassard L., Lübbe A.S. Magnetic ion-exchange nano- and microparticles for medical, biochemical and molecular biological applications. J. of Magnetism and Magnetic Materials 1999; 194: 45-52.
1.02
Sieben S., Bergemann C., Lübbe A.S., Brockmann B., Rescheleit D. Comparison of different particles and methods for magnetic isolation of circulating tumor cells. J. of Magnetism and Magnetic Materials 2001; 225: 175-179.
1.03
Liu Jing Magnetorheological Fluids: From Basic Physics to Application JSME International Journal Series B 2002; 45(1): 55-60.
1.04
Frenzel A., Bergemann C., Köhl G., Reinard T. Novel purification system for 6xHis-tagged proteins by magnetic affinity separation. J. Chromatography B 2003; 793: 325-329.
1.05
Deponte S., Steingroewer J., Löser C., Boschke E. and Bley T. Biomagnetic separation of Escherichia coli by use of anion-exchange beads: measurement and modeling of the kinetics of cell-bead interactions. Anal. Bioanal. Chem. 2004; 379: 419-426.
1.06
Villanueva J., Philip J., Entenberg D., Chaparro C. A., Tanwar M. K., Holland E. C. and Tempst P. Serum Peptide Profiling by Magnetic Particle-Assisted, Automated Sample Processing and MALDI-TOF Mass Spectrometry. Anal. Chem. 2004; 76: 1560-1570.
1.07
Zhang X., Sau-Mei Leung, Claudia R. Morris and Mark K. Shigenaga Evaluation of a Novel, Integrated Approach Using Functionalized Magnetic Beads, Bench-Top MALDI-TOF-MS with Prestructured Sample Supports, and Pattern Recognition Software for Profiling Potential Biomarkers in Human Plasma. Journal of Biomolecular Techniques 2004; 15(3): 167-157.
1.08
Baumann S., Uta Ceglarek, Georg Martin Fiedler, Jan Lembcke, Alexander Leichtle, and Joachim Thiery Standardized Approach to Proteome Profiling of Human Serum Based on Magnetic Bead Separation and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry. Clinical Chemistry 2005; 51(6): 973–980.
1.09
Boschke E., Steingroewer J. und Bley T. Einsatz der biomagnetischen Separation zur mikrobiologischen Qualitätskontrolle von Lebensmitteln Chemie Ingenieur Technik (CIT) 2005; 77(7): 912-919.
1.10
Hillel Haim, Israel Steiner and Amos Panet. Time Frames for Neutralization during the Human Immunodeficiency Virus Type 1 Entry Phase, as Monitored in Synchronously Infected Cell Cultures. J. of Virology 2005; 79 (1): 622-625.
1.11
Jörg Neumann and Ralf Brinkmann. Boiling nucleation on melanosomes and microbeads transiently heated by nanosecond and microsecond laser pulses. Journal of Biomedical Optics 2005; 10(2): 024001-1 - 024001-12.
1.12
Jörg Neumann and Ralf Brinkmann. Nucleation and dynamics of bubbles forming around laser heated microabsorbers. Therapeutic Laser Applications and Laser-Tissue Interactions II 2005; Proc. SPIE Vol. 5863.
1.13
Villanueva J., Philip J., Chaparro C.A., Li Y., Toledo-Crow R., DeNoyer L., Fleisher M., Robbins R.J. and Tempst P. Correcting Common Errors in Identifying Cancer-Specific Serum Peptide Signatures. J. of Proteome Research 2005; 4: 1060-1072.
1.14
Berensmeier S. Magnetic particles for the separation and purification of nucleic acids Appl Microbiol Biotechnol (2006) 73:495–504.
1.15
Franzreb M., Siemann-Herzberg M., Hobley T.J. and Thomas R.T. O. Protein purification using magnetic adsorbent particles. Appl. Microbiol. Biotechnol. 2006; 70: 505–516.
1.16
Prikryl P., Horak D., Ticha M. and Kucerova Z. Magnetic IDA-modified hydrophilic methacrylatebased polymer microspheres for IMAC protein separation. J. Sep. Sci. 2006;29, 2541–2549
1.17
Stratmann J., Karen Dohmann, Julia Heinzmann, and Gerald-F. Gerlach Peptide aMpt-Mediated Capture PCR for Detection of Mycobacterium avium subsp. paratuberculosis in Bulk Milk Samples. APPLIED AND ENVIRONMENTAL MICROBIOLOGY 2006; 72(8): 5150–5158.
1.18
Asgar E., Büssow K., Oster J., Sieper J., Thiel A., Duchmann R. and Adam T. Homologous high-throughput expression and purification of highly conserved E coli proteins. Microbial Cell Factories 2007; 6:18. [purification of endotoxins from protein solution]
1.19
Brizzolara R.A. and Stamper D.M. The effect of covalent surface immobilization on the bactericidal efficacy of a quaternary ammonium compound. Surf. Interface Anal. 2007; 39: 559–566.
1.20
Hillel Haim, Israel Steiner and Amos Panet. Synchronized Infection of Cell Cultures by Magnetically Controlled Virus. J. of Virology 2007; 81 (7): 3525-3534.
1.21
Issle J. and Hartmann U. Scanning force microscopy on spatially and temporally varying magnetic substrates for cell cultivation. Journal of Physics: Conference Series 61 (2007) 487–491.
1.22
Kettering M., Winter J., Zeisberger M., Bremer-Streck S., Oehring H., Bergemann C., Alexiou C., Hergt R., Halbhuber K.J., Kaiser W.A. and Hilger I. Magnetic nanoparticles as bimodal tools in magnetically induced labelling and magnetic heating of tumour cells: an in vitro study. Nanotechnology 2007; 18: 1 – 9.
1.23
Mitchels J., Hawkins P., Luxton R. and Rhodes A. Quantification in histopathology – Can magnetic particles help? Journal of Magnetism and Magnetic Materials 2007; 311: 264-268.
1.24
Sellaro T. L., Ravindra A. K., Stolz D. B. and Badylak S. Maintenance of Hepatic Sinusoidal Endothelial Cell Phenotype In Vitro Using Organ-Specific Extracellular Matrix Scaffolds. Tissue Engineering 2007; 13(9): 2301-2310.
1.25
Steingroewer J., Bley T., Bergemann Ch. and Boschke E. Biomagnetic separation of Salmonella Typhimurium with affine and specific ligand peptides isolated by phage display technique. J. Magnetism Magnet. Materials 2007; 311: 295-299.
1.26
Stolz D. B., Ross M. A., Ikeda A., Tomiyama K, Kaizu T., Geller D. A. and Murase N. Sinusoidal Endothelial Cell Repopulation Following Ischemia/Reperfusion Injury in Rat Liver Transplantation. Hepatology 2007; 46(5): 1464-1475.
1.27
Gammerman A., Vovk V., Burford B., Nouretdinov I., Luo Z., Chervonenkis A., Waterfield M., Cramer R., Tempst P., Villanueva J., Kabir M., Camuzeaux S., Timms J., Menon U. and Jacobs I. Serum Proteomic Abnormality Predating Screen Detection of Ovarian Cancer. The Computer Journal Advance Access published April 15, 2008.
1.28
Hall P. R., Hjelle B., Brown D. C., Ye C., Bondu-Hawkins V., Kilpatrick K. A. and Larson R. S. Multivalent Presentation of Antihantavirus Peptides on Nanoparticles Enhances Infection Blockade. Antimicrobial Agents and Chemotherapy 2008; 52 (6): 2079–2088.
1.29
Issle J.,Mateu Pla-Roca, Elena Martinez and Uwe Hartmann. Patterning of Magnetic Nanobeads on Surfaces by Poly(dimethylsiloxane) Stamps. Langmuir 2008; 24: 888-893.
1.30
Jankovicova B., Rosnerova S., Slovakova M., Zverinova Z., Hubalek M., Hernychova L., Rehulka P., Viovy J-P., Bilkova Z. Epitope mapping of allergen ovalbumin using biofunctionalized magnetic beads packed in microfluidic channels The first step towards epitope-based vaccines Journal of Chromatography A 2008; 1206: 64–71
1.31
Korecká L., Jankovicová B., Krenková J., Hernychová L., Slováková M., Le-Nell A., Chmelik J., Foret F., Viovy J-L., Bilková Z. Bioaffinity magnetic reactor for peptide digestion followed by analysis using bottom-up shotgun proteomics strategy. J. Sep. Sci. 2008; 31: 507 – 515.
1.32
Natividad E., Castro M. and Mediano A. Accurate measurement of the specific absorption rate using a suitable adiabatic magnetothermal setup Appl. Phys. Lett. 2008; 92: 093116-1 — 093116-3.
1.33
Reichardt W., Dürr C., Elverfeldt D. von, Jüttner E., Gerlach U. V., Yamada M., Smith B., Negrin R. S. and Zeiser R. Impact of Mammalian Target of Rapamycin Inhibition on Lymphoid Homing and Tolerogenic Function of Nanoparticle-Labeled Dendritic Cells following Allogeneic Hematopoietic Cell Transplantation The Journal of Immunology 2008; 181: 4770-4779.
1.34
Schaller Vincent; Kräling, Ulli; Rusu, Cristina; Petersson, Karolina; Wipenmyr, Jan; Krozer, Anatol; Wahnström, Göran; Sanz-Velasco, Anke; Enoksson, Peter; Johansson, Christer Motion of nanometer sized magnetic particles in a magnetic field gradient Journal of Applied Physics 2008;104 (9): 093918-093918-14.
1.35
Jankovicova B., Sarka Rosnerova, Marcela Slovakova, Zuzana Zverinova, Martin Hubalek, Lenka Hernychova, Pavel Rehulka, Jean-Louis Viovy, Zuzana Bilkova. Epitope mapping of allergen ovalbumin using biofunctionalized magnetic beads packed in microfluidic channels The first step towards epitope-based vaccines. Journal of Chromatography A 2008; 1206: 64–71.
1.36
Hillel Haim, Zhihai Si, Navid Madani, Liping Wang, Joel R. Courter, Amy Princiotto, Aemro Kassa, Marciella DeGrace, Kathleen McGee-Estrada, Megan Mefford, Dana Gabuzda, Amos B. Smith III, Joseph Sodroski. Soluble CD4 and CD4-Mimetic Compounds Inhibit HIV-1 Infection by Induction of a Short-Lived Activated State. PLoS Pathogens 2009; 5(4): 1-13.
1.37
Lewandrowski U. and Albert Sickmann. N-Glycosylation Site Analysis of Human Platelet Proteins by Hydrazide Affinity Capturing and LC-MS/MS. Methods in Molecular Biology, Glycomics: Methods and Protocols 2009; 534: 225-238.
1.38
Mahowald J. Delphine Arcizet and Doris Heinrich Impact of External Stimuli and Cell Micro-Architecture on Intracellular Transport States ChemPhysChem 2009, 10, 1559 – 1566.
1.39
Tseng P., Dino Di Carlo and Jack W. Judy Rapid and Dynamic Intracellular Patterning of Cell-Internalized Magnetic Fluorescent Nanoparticles. Nano Letters 2009 Revised Manuscript Received June 18, 2009
1.40
Kottakis F., Christina Befani, Antonios Asiminas, Maria Kontou, Georgios Koliakos and Theodora Choli-Papadopoulou The C-terminal Region of HPNAP Activates Neutrophils and Promotes Their Adhesion to Endothelial Cells Helicobacter 2009,1:177–179.
1.41
Schaller Vincent, Göran Wahnström, Anke Sanz-Velasco, Peter Enoksson and Christer Johansson Monte Carlo simulation of magnetic multi-core nanoparticles Journal of Magnetism and Magnetic Materials 2009; 321 (10): 1400-1403.
1.42
Schaller Vincent, Goran Wahnstrom, Anke Sanz- Velasco, Stefan Gustafsson, Eva Olsson, Peter Enoksson, and Christer Johansson Effective magnetic moment of magnetic multicore nanoparticles 2009 in press.
1.43
Schaller Vincent, Anke Sanz- Velasco, Alexey Kalabukhov, Justin F. Schneidermann, Fredrik Öisjöen, Aldo Jesorka, Andrea Prieto Astalan, Anatol Krozer, Christina Rusu, Peter Enoksson, and Dag Winkler Towards an electrowetting-based digital microfluidic platform for magnetic immunoassays 2009 in press.
1.44
Natividad E., Miguel Castro, Arturo Mediano Adiabatic vs. non-adiabatic determination of specific absorption rate of ferrofluids. Journal of Magnetism and Magnetic Materials 2009; 321: 1497-1500.
1.45
Zhang L., Yawei Xu, Hailiang Yao, Liqi Xie, Jun Yao, Haojie Lu and Pengyuan Yang. Boronic Acid Functionalized Core–Satellite Composite Nanoparticles for Advanced Enrichment of Glycopeptides and Glycoproteins. Chem. Eur. J. 2009; 15: 10158–10166.
1.46
Lavilla M. Ruth De Luis, María Dolores Pérez, Miguel Calvo, Lourdes Sánchez. Selection of high affine peptide ligands for detection of ClostridiumTyrobutyricumspores. Journal of Microbiological Methods 2009; 79: 214–219.
1.47
Guo Zhongxian, Ying Liu, Shuping Li and Zhaoguang Yang. Interaction of bacteria and ionexchange particles and its potential in separation for matrix-assisted laser desorption / ionization mass spectrometric identification of bacteria in water. Rapid Commun. Mass Spectrom. 2009; 23: 3983–3993.
1.48
Jaetao Jason E., Kimberly S. Butler, Natalie L. Adolphi, Debbie M. Lovato, Howard C. Bryant, Ian Rabinowitz, Stuart S. Winter, Trace E. Tessier, Helen J. Hathaway, Christian Bergemann, Edward R. Flynn and Richard S. Larson. Enhanced Leukemia Cell Detection Using a Novel Magnetic Needle and Nanoparticles. Cancer Res 2009; 69 (21): 8310–8316.
1.49
Pedersen M. B., Zhou X., Larsen E.K.U., Sørensen U. S., Kjems J., Nygaard J.V., Nyengaard J.R., Meyer R.L., Boesen T. and Jensen. Curvature of Synthetic and Natural Surfaces Is an Important Target Feature in Classical Pathway Complement Activation. The Journal of Immunology 2010; 184: 1931-1945.

References - Detection

2.01
Hilger I., Hofmann F., Reichenbach J.R., Bergemann C., Hiergeist R., Andrä W., Hergt R., Kaiser W.A. In vitro imaging of magnetite particles. RöFo 2001; Band: 173.
2.02
Lind K., Kresse M., Müller R. Comparison of protein adsorption patterns onto differently charged hydrophilic superparamagnetic iron oxide particles obtained in vitro and ex vivo. Electrophoresis 2001; 22: 3514-3521.
2.03
Lind K., Kresse M., Debus N. P. and Müller R. H. A Novel Formulation for Superparamagnetic Iron Oxide (SPIO) Particles Enhancing MR Lymphography: Comparison of Physicochemical Properties and The in vivo Behaviour. J. Drug Targeting 2002; 10 (3): 221-230.
2.04
Eberbeck D., Bergemann C., Hartwig S., Steinhoff U. and Trahms L. Binding kinetics of magnetic nanoparticles on latex beads studied by magnetorelaxometry. Appl. Organometal. Chem. 2004; 18: 542-547.
2.05
Eberbeck D., Bergemann C., Hartwig S., Steinhoff U. and Trahms L. Binding kinetics of magnetic nanoparticles on latex beads and yeast cells studied by magnetorelaxometry. J. of Magnetism and Magnetic Materials 2005; 289: 435-438.
2.06
Flynn E. R. and Bryant H.C. A biomagnetic system for in vivo cancer imaging. Phys. Med. Biol. 2005; 50: 1273-1293.
2.07
Häfeli Urs O., Lobedann M. A., Steingroewer J., Moore Lee R. and Riffled J. Optical method for measurement of magnetophoretic mobility of individual magnetic microspheres in defined magnetic field. Journal of Magnetism and Magnetic Materials 2005; 293: 224–239.
2.08
Eberbeck D., Wiekhorst F., Steinhoff U. and Trahms L. Aggregation behaviour of magnetic nanoparticle suspensions investigated by magnetorelaxometry. J. Phys.: Condens. Matter 2006; 18: 2829-2846.
2.09
Kettering M. et al. Magnetically Based Enhancement of Nanoparticle Uptake in Tumor Cells: Combination of Magnetically Induced Cell Labeling and Magnetic Heating. Fortschr. Röntgenstr. 2006; 178: 1255-1260.
2.10
Bryant H.C., Sergatskov D.A., Lovato D., Adolphi N.L., Larson R.S. and Flynn E.R. Magnetic needles and superparamagnetic cells. Phys. Med. Biol. 2007; 52: 4009-4025.
2.11
Flynn E.R., Bryant H.C., Bergemann Ch. et al. Use of a SQUID array to detect T-cells with magnetic nanoparticles in determining transplant rejection. J. Magnetism Magnet. Materials 2007; 311: 429-435.
2.12
Ludwig F., Heim E. and Schilling M. Characterization of superparamagnetic nanoparticles by analyzing the magnetization and relaxation dynamics using fluxgate magnetometers. J. of Applied Physics 2007; 101: (113909) 1 – 10.
2.13
Kettering M., Winter J., Zeisberger M., Bremer-Streck S., Oehring H., Bergemann C., Alexiou C., Hergt R., Halbhuber J., Kaiser W. and Hilger I. Magnetic nanoparticles as bimodal tools in magnetically induced labelling and magnetic heating of tumour cells: an in vitro study. Nanotechnology 2007; 18: 175101 (9pp).
2.14
Eberbeck D., Bergemann C., Wiekhorst F., Steinhoff U. and Trahms L. Quantification of specific bindings of biomolecules by magnetorelaxometry. J. of Nanobiotechnology 2008; 6: 4.
2.15
Öisjöen F., Magnelind P., Kalabukhov A. and Winkler D. High-Tc SQUID gradiometer system for immunoassays. Supercond. Sci. Technol. 2008; 21: 1-4.
2.16
Jia W., Xua G., Sclabassia R. J., Zhu J-G, Bagic A., Suna M. Detection of magnetic nanoparticles with magnetoencephalography J. of Magnetism and Magnetic Materials 2008; 320: 1472–1478.
2.17
Chertok B, Moffat BA, David AE, Yu F, Bergemann C, Ross BD, Yang VC. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials. 2008 Feb;29(4):487-96.
2.18
Gonzalez-Lara, Xiaoyun Xu, Klara Hofstetrova, Anna Pniak, Arthur Brown and Paula J. Foster In Vivo Magnetic Resonance Imaging of Spinal Cord Injury in the Mouse. JOURNAL OF NEUROTRAUMA 2009; 26:753–762.
2.19
Adolphi N.L., Dale L. Huber, Jason E. Jaetao, Howard C. Bryant, Debbie M. Lovato, Danielle L. Fegan, Eugene L. Venturini, Todd C. Monson, Trace E. Tessier, Helen J. Hathaway, Christian Bergemann, Richard S. Larson, Edward R. Flynn. Characterization of magnetite nanoparticles for SQUID-relaxometry and magnetic needle biopsy. Journal of Magnetism and Magnetic Materials 2009; 321: 1459–1464.
2.20
Heim E., Frank Ludwig, Meinhard Schilling Binding assays with streptavidin-functionalized superparamagnetic nanoparticles and biotinylated analytes using fluxgate magnetorelaxometry. J. of Magnetism and Magnetic Materials 2009; 321: 1628-1631.
2.21
Ludwig F., Erik Heim, Meinhard Schilling Characterization of magnetic core-shell nanoparticles by fluxgate magnetorelaxometry, ac susceptibility, transmission electron microscopy and photon correlation spectroscopy-A comparative study. J. of Magnetism and Magnetic Materials 2009; 321: 1644-1647.
2.22
Goodwill PW, Scott GC, Stang PP, Conolly SM. Narrowband magnetic particle imaging. IEEE Trans Med Imaging. 2009;28(8):1231-1237.
2.23
Yusdy, Sohan R. Patel, Miranda G.S. Yapa, Daniel I.C. Wanga. Immobilization of l-lactate dehydrogenase on magnetic nanoclusters for chiral synthesis of pharmaceutical compounds. Biochemical Engineering Journal xxx (2009) xxx–xxx. Article in press.
2.24
Richter H., Kettering M., Wiekhorst F., Steinhoff U., Hilger I.and Trahms T. Magnetorelaxometry for localization and quantification of magnetic nanoparticles for thermal ablation studies. Phys.Med.Biol. 2010; 55: 623–633.

References - Magnetofection™

3.001
Plank C., Scherer F., Schillinger U., Anton M. Magnetofection: Enhancement and localization of gene delivery with magnetic particles under influence of a magnetic fields. J. Gene Med. 2000; 2((5) Suppl.): S24.
3.002
Scherer F., Anton M., Schillinger U., Henke J., Bergemann C., Krüger A., Gänsbacher B. and Plank C. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Therapy 2002; 9: 102-109.
3.003
Plank C., Schillinger U., Scherer F., Bergemann C., Remy J.-S., Krötz F., Anton M., Lausier J. and Rosenecker J. The Magnetofection Method: Using Magnetic Force to Enhance Gene Delivery. Biol. Chem. May 2003; 384: 737-747.
3.004
Plank C., Anton M., Rudolph C., Rosenecker J. and Krötz F. Enhancing and targeting nucleic acid delivery by magnetic force. Expert Opinion on Biological Therapy 2003; 3: 745-758.
3.005
Plank C., Scherer F., Schillinger U., Bergemann C., Anton M. Magnetofection: enhancing and targeting gene delivery with superparamagnetic nanoparticles and magnetic fields. J. Liposome Res. 2003; 13(1): 29-32.
3.006
Plank C. Magnetofection: enhancing and targeting gene delivery with lipid-DNA vectors by magnetic force. J. Liposome Res. 2003; 13(1): 105-106.
3.007
Krötz F., Son HY., Gloe T., Planck C. Magnetofection Potentiates Gene Delivery to Cultured Endothelial. Journal of Vascular Research 2003; 40: 425-434.
3.008
Krötz F., Wit C., Sohn HY., Zahler S., Gloe T., Pohl U. and Plank C. Magnetofection-A highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo. Mol. Ther. May 2003; 7(5): 700-710.
3.009
Bridell H. Magnetic field guided nucleic acid delivery to target the Raf-1 kinase in human umbilical vein endothelial cells. Master thesis in medical science 2003, Technical University of Munich, Germany.
3.010
Gersting S-W., Schillinger U., Lausier J., Nicklaus P., Rudolph C., Plank C., Reinhardt D. and Rosenecker J. Gene delivery to respiratory epithelial cells by magnetofection. J.Gene Medicine 2004; 6: 913-922.
3.011
Griesenbach U., Duncan M. Geddes and Eric W.F.W. Alton. Advances in cystic fibrosis gene therapy. Current Opinion in Pulmonary Medicine 2004; 10: 542-546.
3.012
Huth S., Lausier J., Gersting S-W., Rudolph C., Plank C., Welsch U. and Rosenecker J. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J.Gene Medicine 2004; 6: 923-936.
3.013
Rashmi K. Ambasta, Pravir Kumar et al. Direct Interaction of the Novel Nox Proteins with p22phox Is required for the Formation of a Functionally Active NADPH Oxidase. J. of Biological Chem. 2004; 279 (44): 45935-45941.
3.014
Weizhong W., XU Chunfang, WU Hua Use of PEI-coated Magnetic Iron Oxide Nanoparticles as Gene Vectors Journal of Huazhong University of Science and Technology (Med. Sci.) 2004; 24 (6): 618-620.
3.015
Basile J. R.,Talayeh Afkhami and J. Silvio Gutkind. Semaphorin 4D/Plexin-B1 Induces Endothelial Cell Migration through the Activation of PYK2, Src, and the Phosphatidylinositol 3-Kinase-Akt Pathway. Molecular and Cellular Biology 2005; 25 (16): 6889-6898.
3.016
Kadota S., Kanayama T., Miyajima N., Takeuchi K. And Nagata K. Enhancing of measles virus infection by magnetofection. J. of Virol. Methods 2005; 128(1-2): 61-66.
3.017
Chudotvorova I., Ivanov A., Rama S., Hübner C.A., Pellegrino C., Ben-Ari Y. And Medina I. Early expression of KCC2 in rat hippocampal cultures augments expression of functional GABA synapses. J. Physiol. 2005; 566.3: 671-679.
3.018
Fransen M., Ilse Vastiau, Chantal Brees, Vanessa Brys Guy P. Mannaerts and Paul P. Van Veldhoven. Analysis of Human Pex19p's Domain Structure by Pentapeptide Scanning Mutagenesis. J. Mol. Biol. 2005; 346: 1275-1286.
3.019
Goulimari P. et al. 12/13 Is Essential for Directed Cell Migration and Localized Rho-Dia1 Function. JBC 2005; 280 (51): 42242-42251.
3.020
Hollander K., Michal Bar-Chen, Shimon Efrat. Baculovirus p35 increases pancreatic b-cell resistance to apoptosis. Biochemical and Biophysical Research Communications 2005; 332: 550-556.
3.021
Krötz F., Engelbrecht B., Buerkle MA., Bassermann F., Bridell H., Gloe T., Duyster J., Pohl U. and Sohn HY. The tyrosine phosphatase, SHP-1, is a negative regulator of endothelial superoxide formation. J. Am. Coll. Cardiol. 2005; 45(10): 1700-1706.
3.022
Recklies A.D., Hua Ling, Chantal White, and Suzanne M. Bernier. Inflammatory Cytokines Induce Production of CHI3L1 by articular Chondrocytes J. of Biol. Chem. 2005; 280 (50): 41213-41221.
3.023
Uchida Y. et al. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3β phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease Genes to Cells 2005; 10: 165-179.
3.024
Ulrike Schillinger et al. Advances in magnetofection-magnetically guided nucleic acid delivery. Journal of Magnetism and Magnetic Materials 2005; 293: 501-508.
3.025
Kumbrink J., Gerlinger M. and Johnson J. P. Egr-1 Induces the Expression of Its Corepressor Nab2 by Activation of the Nab2 Promoter Thereby Establishing a Negative Feedback Loop. JBC 2005; 280 (52): 42785-42793.
3.026
Liman J. et al. Interaction of BAG1 and Hsp70 Mediates Neuroprotectivity and Increases Chaprone Activity. Mol. and Cell. Biology 2005; 25 (9): 3715-3725.
3.027
Stadler S. C., Roman Polanetz, Stephan Meier, Peter U. Mayerhofer, Johannes M. Herrmann, Katja Anslinger, Adelbert A. Roscher, Wulf Röschinger, Andreas Holzinger Mitochondrial targeting signals and mature peptides of 3-methylcrotonyl-CoA carboxylase Biochemical and Biophysical Research Communications 2005; 334:939-946.
3.028
Basile J. R., Rogerio M. Castilho, Vanessa P. Williams and J. Silvio Gutkind. Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. PNAS 2006; 103 (24): 9017-9022.
3.029
Doshida M. et al. Raloxifene Increases Proliferation and Up-regulates Telomerase Activity in Human Umbilical Vein Endothelial Cells. The Journal of Biological Chemistry 2006; 281 (34): 24270-24278.
3.030
Kamau Sarah W. et al. Enhancement of the efficiency of non-viral gene delivery by application of pulsed magnetic field. Nucleic Acid Research 2006; 34 (5).
3.031
Kaneko M., Weiwen Yang, Yoshiki Matsumoto, Fujiko Watt, Keiko Funa. Activity of a novel PDGF β-receptor enhancer during the cell cycle and upon differentiation of neuroblastoma. Experimental Cell Research 2006; 312: 2028-2039.
3.032
Kaur S. et al. Robo4 Signaling in Endothelial Cells Implies Attraction Guidance Mechanisms. J. of Biol. Chem. 2006; 281 (16): 11347-11356.
3.033
Kim E-A., Yoon Tae Noh, Myung-Jeom Ryu, Hyun-Taek Kim, Sung-Eun Lee, Cheol-Hee Kim, Cheolju Lee, Young Ho Kim and Cheol Yong Choi. Phosphorylation and Transactivation of Pax6 by Homeodomain-interacting Protein Kinase 2. J. of Biolog. Chem. 2006; 281 (11): 7489-7497.
3.034
Nagata D., Takahashi M., Sawai K., Tagami T., Usui T., Shimatsu A., Hirata Y., Naruse M. Molecular Mechanism of the Inhibitory Effect of Aldosterone on Endothelial NO Synthase Activity. Hypertension 2006; 48: 165-171.
3.035
Pasder O. et al. Downregulation of Fer induces PP1 activation and cell-cycle arrest in malignant cells. Oncogene 2006; 25: 4194-4206.
3.036
Pinto M.P., Grou C.P., Alencastre I.S., Oliveira M.E., Miranda C.S., Fransen M. and Azevedo J.E. The Import Competence of a Peroxisomal Membrane Protein Is Determined by Pex19p before the Docking Step. The J. of Biolog. Chem. 2006; 281(45): 34492-34502.
3.037
Romero D. G., Welsh B.L., Gomez-Sanchez E.P., Yanes L.L., Rilli S. and Gomez-Sanchez C.E. Angiotensin II-Mediated Protein Kinase D Activation Stimulates Aldosterone and Cortisol Secretion in H295R Human Adrenocortical Cells. Endocrinology 2006; 147(12): 6046-6055.
3.038
Sapet C., Simoncini S., Loriod B., Puthier D., Sampol J., Nguyen C., Dignat-George F. and Anfosso F. Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. Blood 2006; 108: 1868-1876.
3.039
Seki T., Irie N., Nakamura K., Sakaue H., Ogawa W., Kasuga M., Yamamoto H., Ohmori S., Saito N. and Sakai N. Fused protein of δPKC activation loop and PDK1-interacting fragment (δAL-PIF) functions as a pseudosubstrate and an inhibitory molecule for PDK1 when expressed in cells. Genes to Cells 2006; 11: 1051-1070.
3.040
Wang J., Zhang Y, Wei J., Zhang X., Zhang B., Zhu Z., Zou W., Wang Y., Mou Z., Ni B. and Wu Y. Lewis X oligosaccharides targeting to DC-SIGN enhanced antigen-specific immune response. Immunology 2006; 121: 174-182.
3.041
Weizhong W., Xu C., Wu H. Magnetic Iron Oxide Nanoparticles Mediated Gene Therapy for Breast Cancer - An In Vitro Study. Journal of Huazhong University of Science and Technology (Med. Sci.) 2006; 26 (6): 728-730.
3.042
Xenariou S. et al. Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo. Gene Therapy 2006; 1-8.
3.043
McCAIG C et al. The Role of Matrix Metalloproteinase-7 in Redefining the astric Microenvironment in Response to Helicobacter pylori. Gastroenterology 2006; 130:1754-1763.
3.044
Minami R., Yamamoto M., Takahama S., Miyamura T., Watanabe H., Suematsu E. RCAS1 induced by HIV-Tat is involved in the apoptosis of HIV-1 infected and uninfected CD4+ T cells. Cellular Immunology 2006; 243: 41-47.
3.045
Mizutani C. et al. Mechanisms of establishment of persistent SARS-CoV-infected cells. Biochemical and Biophysical Research Communications 2006; 347: 261-265.
3.046
Mizutani C. et al. Inhibition of cell proliferation by SARS-CoV infection in Vero E6 cells. FEMS Immunol Med Microbiol 2006; 46: 236-243.
3.047
Mukai H.Y., Motohashi H., Ohneda O., Suzuki N., Nagano M. and Yamamoto M. Transgene Insertion in Proximity to the c-myb Gene Disrupts Erythroid-Megakaryocytic Lineage Bifurcation. Mol. and Cell. Biology 2006; 26 (21): 7953-7965.
3.048
Rubic T., Reinhard L. Lorenz Downregulated CD36 and oxLDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10. Cardiovascular Research 2006; 69: 527-535.
3.049
Kojima T., Ken-ichi Nakahama, Kiyotaka Yamamoto, Hiroshi Uematsu and Ikuo Morita Age- and cell cycle-dependent changes in EPC-1/PEDF promoter activity in human diploid fibroblast-like (HDF) cells. Molecular and Cellular Biochemistry 2006; 293: 63-69.
3.050
Baer K., Bürli T., Huh K-H, Wiesner A., Erb-Vögtli S., Göckeritz-Dujmovic D., Moransard M., Nishimune A., Rees M.I., Henley J.M., Fritschy J-M and Fuhrera C. PICK1 interacts with α7 neuronal nicotinic acetylcholine receptors and controls their clustering. Mol. Cell. Neurosci. 2007; 35: 339-355.
3.051
Basile J.R., Holmbeck K., Bugge T.H. and Gutkind J.S. MT1-MMP Controls Tumor-induced Angiogenesis through the Release of Semaphorin 4D. J. of Biolog. Chem. 2007; 282 (9): 6899-6905.
3.052
Buerli T., Pellegrino C., Baer K., Lardi-Studler B., Chudotvorova I., Fritschy J-M., Medina I. and Fuhrer C. Efficient transfection of DNA or shRNA vectors intoneurons using Magnetofection NATURE PROTOCOLS 2007; 2(12): 3090-3101.
3.053
Couchoux H., Allard B., Legrand C., Jacquemond V. and Berthier C. Loss of caveolin-3 induced by the dystrophy-associated P104L mutation impairs L-type calcium channel function in mouse skeletal muscle cells. J. of Physiol. 2007; 580.3: 745-754.
3.054
Deleuze V., Chalhoub E., El-Hajj R., Dohet C., Le Clech M., Couraud P-O., Philippe H. and Mathieu D. TAL-1/SCL and Its Partners E47 and LMO2 Up-Regulate VE-Cadherin Expression in Endothelial Cells. Mol. and Cell. Biology 2007; 27 (7): 2687-2697.
3.055
Eder P., D. Probst, C. Rosker, M. Poteser, H. Wolinski, S.D. Kohlwein, C. Romanin, K. Groschner Phospholipase C-dependent control of cardiac calcium homeostasis involves a TRPC3-NCX1 signaling complex. Cardiovascular Research 2007; 73: 111-119.
3.056
Fukushima T., Tezuka T., Shimomura T., Nakano S. and Kataoka H. Silencing of Insulin-like Growth Factor-binding Protein-2 in Human Glioblastoma Cells Reduces Both Invasiveness and Expression of Progression-associated Gene CD24. J. of Biolog. Chem. 2007; 282 (25): 18634-18644.
3.057
Jahnke A., Hirschberger J., Fischer C., Brill T., Köstlin R., Plank C., Küchenhoff H., Krieger S., Kamenica K. and Schillinger U. Intra-tumoral Gene Delivery of feIL-2, feIFN-c and feGM-CSF using Magnetofection as a Neoadjuvant Treatment Option for Feline Fibrosarcomas: A Phase-I Study. J. Vet. Med. A 2007; 54: 1-8.
3.058
Romero D.G., Yanes L.L., de Rodriguez A.F., Plonczynski M.W., Welsh B.L., Reckelhoff J.F., Gomez-Sanchez E.P. and Gomez-Sanchez C.E. Disabled-2 (Dab2) is Expressed in Adrenal Zona Glomerulosa and is Involved in Aldosterone Secretion. Endocrinology 2007, First published ahead of print February 15, 2007 as doi:10.1210/en. 2006-1509.
3.059
Romero D.G., Rilli S., Plonczynski M.W., Yanes L.L., Zhou M.Y., Gomez-Sanchez E.P. and Gomez-Sanchez C.E. Adrenal transcription regulatory genes modulated by angiotensin II and their role in steroidogenesis. Physiol. Genomics 2007; 30: 26-34.
3.060
Sacha J.B., Chung C., Rakasz E.G., Spencer S.P., Jonas A.K., Bean A.T., Lee W., Burwitz B.J., Stephany J.J., Loffredo J.T, Allison D.B., Adnan S., Hoji A., Wilson N.A., Friedrich T.C., Lifson J.D., Yang O.O. and Watkins D.I. Gag-Specific CD8+ T Lymphocytes Recognize Infected Cells before AIDS-Virus Integration and Viral Protein Expression. The Journal of Immunology 2007; 178: 2746-2754.
3.061
Steele I.A., Rod Dimaline R., Pritchard D.M., Peek Jr. R.M., Wang T.C., Dockray G.J. and Varro A. Helicobacter and gastrin stimulate Reg1 expression in gastric epithelial cells through distinct promoter elements. Am. J. Physiol. Gastrointest. Liver Physiol. 2007; 293: G347-G354.
3.062
Schäfer C., Hoffmann L., Heldt K., Reza M., Lornejad-Schäfer, Brauers G., Gehrmann T., Garrow T.A., Häussinger D., Mayatepek E., Schwahn B.C. and Schliess F. Osmotic regulation of betaine homocysteine-S-methyltransferase expression in H4IIE rat hepatoma cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2007; 292:1089-1098.
3.063
Tan Z., X Sun, F-S Hou, H-W Oh, LGW Hilgenberg, EM Hol, FW van Leeuwen, MA Smith, DK O'Dowd and SS Schreiber. Mutant ubiquitin found in Alzheimer's disease causes neuritic beading of mitochondria in association with neuronal degeneration. Cell Death and Differentiation 2007; 14: 1721-1732.
3.064
Nakamura A., Yukiko Sakai, Chieri Ohata, Toshi Komurasaki. Expression and significance of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-1 in an animal model of renal interstitial fibrosis induced by unilateral ureteral obstruction. Experimental and Toxicologic Pathology 2007; 59: 1-7.
3.065
McBain S.C., H. H. P. Yiu, A. El Haj and J. Dobson. Polyethyleneimine functionalized iron oxide nanoparticles as agents for DNA delivery and transfection. Journal of Materials Chemistry 2007; 17: 2561-2565.
3.066
Huang P., T Senga and M Hamaguchi. A novel role of phospho-b-catenin in microtubule regrowth at centrosome. Oncogene 2007; 26: 4357-4371.
3.067
Hasegawa T., Toshiyuki Matsuzaki, Yuki Tajika, Abduxukur Ablimit, Takeshi Suzuki, Takeo Aoki Haruo Hagiwara, Kuniaki Takata. Differential localization of aquaporin-2 and glucose transporter 4 in polarized MDCK cells. Histochem Cell Biol 2007; 127: 233-241.
3.068
Guix S., Miyuki Asanaka, Kazuhiko Katayama, Sue E. Crawford, Frederick H. Neill, Robert L. Atmar, and Mary K. Estes. Norwalk Virus RNA Is Infectious in Mammalian Cells. Journal of Virology 2007; 81(22): 12238-12248.
3.069
Varro A., Kenny S., Hemers E., McCaig C., Przemeck S., Wang T.C., Bodger K. and Pritchard D.M. Increased gastric expression of MMP-7 in hypergastrinemia and significance for epithelial-mesenchymal signalling. Am. J. Physiol. Gastrointest. Liver Physiol. 2007; 292: G1133-G1140.
3.070
Lardi-Studler B., Smolinsky B., Petitjean C.M., Koenig F., Sidler C., Meier J.C., Fritschyl J-M. and Schwarz G. Vertebrate-specific sequences in the gephyrin E-domain regulate cytosolic aggregation and postsynaptic clustering. Journal of Cell Science 2007; 120: 1371-1382.
3.071
Lartigue G., Dimaline R., Varro A. and Dockray G.J. Cocaine- and Amphetamine-Regulated Transcript: Stimulation of Expression in Rat Vagal Afferent Neurons by Cholecystokinin and Suppression by Ghrelin. The Journal of Neuroscience 2007; 27(11): 2876 -2882.
3.072
Mykhaylyka O., Vlaskoua D., Tresilwised N., Pithayanukul P, Möller W., Plank C. Magnetic nanoparticle formulations for DNA and siRNA delivery. J.of Magnetism and Magnetic Materials 2007; 311: 275-281.
3.073
Mykhaylyk O., Antequera Y.S., Vlaskou D. & Plank Ch. Generation of magnetic nonviral gene transfer agents and Magnetofection in vitro. Nature Protocols 2007; 2(10): 1-21.
3.074
Yim H-J., Kim H-J., Ko J-H., Cho Y-E., Kim S-M., Kim J-Y., Lee S. and Park J-H. The putative tumor suppressor gene GLTSCR2 induces PTEN-modulated cell death. Cell Death and Differentiation 2007; 1-8.
3.075
Yim Ji-Hye, Yong-Jun Kim, Young-Eun Cho, Jeong-Hun Ko, Su-Mi Kim, Jee-Youn Kim, Jae-Hoon Park. GLTSCR2 Sensitizes Cells to Hypoxic Injury without Involvement of Mitochondrial Apoptotic Cascades Pathobiology 2007;74:301-308.
3.076
Yoon W. S., Won Cheol Choi, Jeong-Im Sin, Yong Keun Park Antitumor therapeutic effects of Salmonella typhimurium containing Flt3 Ligand expression plasmids in melanoma-bearing mouse. Biotechnology Letters 2007; 29:511-516.
3.077
Thomas J.A., Ott D.E. and Gorelick R.J. Efficiency of Human Immunodeficiency Virus Type 1 Postentry Infection Processes: Evidence against Disproportionate Numbers of Defective Virions. Journal of Virology 2007; 81 (8): 4367-4370.
3.078
Arnoux V., Mayssaa Nassour, Annie L'Helgoualc'h, Robert A. Hipskind and Pierre Savagner. Erk5 Controls Slug Expression and Keratinocyte Activation during Wound Healing. Molecular Biology of the Cell 2008; 19: 4738-4749.
3.079
Ashurst H.L., Andrea Varro and Rod Dimaline. Regulation of mammalian gastrin/CCK receptor (CCK2R) expression in vitro and in vivo. Experimental Physiology 2008; 93.2: 223-236.
3.080
Bataille A.M., James Goldmeyer, and J. Larry Renfro. Avian renal proximal tubule epithelium urate secretion is mediated by Mrp4. Am J Physiol Regul Integr Comp Physiol 2008; 295: R2024-R2033.
3.081
Burdyga G., Guillaume de Lartigue, Helen E. Raybould, Richard Morris, Rod Dimaline, Andrea Varro, David G. Thompson and Graham J. Dockray. Cholecystokinin Regulates Expression of Y2 Receptors in Vagal Afferent Neurons Serving the Stomach. The Journal of Neuroscience 2008; 28(45):11583-11592.
3.082
Cestéle S., Paolo Scalmani, Raffaella Rusconi, Benedetta Terragni, Silvana Franceschetti and Massimo Mantegazza. Self-Limited Hyperexcitability: Functional Effect of a Familial Hemiplegic Migraine Mutation of the Nav1.1 (SCN1A) Na+ Channel. The Journal of Neuroscience 2008; 28(29): 7273-7283.
3.083
Dobson J., SC McBain, N Farrow, CD Batich. Oscillating magnet arrays for enhanced magnetic nanoparticle-based gene transfection. European Cells and Materials 2008; 16 Suppl. 3: (page 48).
3.084
Choi S. M., Cho H-J., Cho H., Kim K. H., Kim J. B. and Park H. Stra13/DEC1 and DEC2 inhibit sterol regulatory element binding protein-1c in a hypoxia-inducible factordependet mechanism. Nucleic Acids Research 2008; Published October 5: 1-14.
3.085
Francois M., Andrea Caprini, Brett Hosking, Fabrizio Orsenigo, Dagmar Wilhelm, Catherine Browne, Karri Paavonen, Tara Karnezis, Ramin Shayan, Meredith Downes, Tara Davidson, Desmond Tutt, Kathryn S. E. Cheah, Steven A. Stacker, George E. O. Muscat, Marc G. Achen, Elisabetta Dejana & Peter Koopman. Sox18 induces development of the lymphatic vasculature in mice NATURE 2008; 456:643-648.
3.086
Guillaud L., Wong R. and Hirokawa N. Disruption of KIF17-Mint1 interaction by CaMKIIdependent phosphorylation: a molecular model of kinesin-cargo release. Nature Cell Biology 2008; 10 (1): 19-29.
3.087
Hüttinger C., Hirschberger J., Jahnke A., Köstlin R., Brill T., Plank C., Küchenhoff H., Krieger S. and Schillinger U. Neoadjuvant gene delivery of feline granulocyte-macrophage colony-stimulating factor using magnetofection for the treatment of feline fibrosarcomas: a phase I trial. J. of Gene Med. 2008; 10: 655-667.
3.088
Kim Y.-B., Suyong Choi, Moon-Chang Choi, Min-A Oh, Sin-Ae Lee, Moonjae Choy, Kensaku Mizuno, Sung-Hoon Kim and Jung Weon Lee. Cell Adhesion-dependent Cofilin Serine 3 Phosphorylation by the Integrin-linked Kinase c-Src Complex. J. of Biolog. Chem. 2008; 283 (15): 10089-10096.
3.089
Kojima A., Ken-ichi Nakahama, Kyoko Ohno-Matsui, Noriaki Shimada, Keisuke Mori, Sachiko Iseki, Tetsuji Sato, Manabu Mochizuki, Ikuo Morita. Connexin 43 contributes to differentiation of retinal pigment epithelial cells via cyclic AMP signalling. Biochemical and Biophysical Research Communications 2008; 366: 532-538.
3.090
Kuczewski N., Christophe Porcher, Nadine Ferrand, Hervé Fiorentino, Christophe Pellegrino, Richard Kolarow, Volkmar Lessmann, Igor Medina and Jean-Luc Gaiarsa. Backpropagating Action Potentials Trigger Dendritic Release of BDNF during Spontaneous Network Activity. The Journal of Neuroscience 2008; 28(27): 7013-7023.
3.091
Lee C. H., Kim E. J., Jeon K., Tae J. C., Lee K. S., Kim Y. O., Jeong M.-Y., C.-W. Yun et. al. Simple, Efficient, and Reproducible Gene Transfection of Mouse Embryonic Stem Cells by Magnetofection. Stem Cells and Development 2008; 17:133-141.
3.092
Mannell H., Nicole Hellwig, Torsten Gloe, Christian Plank, Hae-Young Sohn, Leopold Groesser, Barbara Walzog, Ulrich Pohl, Florian Krötz. Inhibition of the Tyrosine Phosphatase SHP-2 Suppresses Angiogenesis in vitro and in vivo. Journal of Vascular Research 2008; 45: 153-163.
3.093
Markova O., Marat Mukhtarov, Eleonore Real, Yves Jacob, Piotr Bregestovski. Genetically encoded chloride indicator with improved sensitivity. Journal of Neuroscience Methods 2008; 170: 67-76.
3.094
Matchkov V.V., Per Larsen, Elena V. Bouzinova, Aleksandra Rojek, Donna M. Briggs Boedtkjer, Veronika Golubinskaya, Finn Skou Pedersen, Christian Aalkjær and Holger Nilsson. Bestrophin-3 (Vitelliform Macular Dystrophy 2-Like 3 Protein) Is Essential for the cGMP-Dependent Calcium-Activated Chloride Conductance in Vascular Smooth Muscle Cells. Circ. Res. 2008;103: 864-872.
3.095
McBain S.C., U. Griesenbach, S. Xenariou, A. Keramane, C.D. Batich, E.W.F.W. Alton and J. Dobson. Magnetic nanoparticles as gene delivery agents: enhanced transfection in the presence of oscillating magnet arrays. Nanotechnology 2008; 19: 405102 (5pp).
3.096
Mukhtarov M., Markova O., Real E., Jacob Y., Buldakova S., Bregestovski P. Monitoring of chloride and activity of glycine receptor channels using genetically encoded fluorescent sensors. Phil. Trans. R. Soc. A 2008; 366: 3445-3462.
3.097
Sbai O., Lotfi Ferhat, Anne Bernard, Yatma Gueye, Adlane Ould-Yahoui, Sophie Thiolloy, Eliane Charrat, Gérard Charton, Evelyne Tremblay, Jean-Jacques Risso, Jean-Paul Chauvin, Jean-Pierre Arsanto, Santiago Rivera, Michel Khrestchatisky. Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells. Molecular and Cellular Neuroscience 2008; 39: 549-568.
3.098
Ufer C., Chi Chiu Wang, Michael Fähling, Heike Schiebel, Bernd J. Thiele, E. Ellen Billett, Hartmut Kuhn and Astrid Borchert. Translational regulation of glutathione peroxidase 4 expression through guaninerich sequence-binding factor 1 is essential for embryonic brain development. Genes & Development 2008; 22: 1838-1850.
3.099
Yamaguchi T., Yoshihisa Watanabe, Masaki Tanaka, Masanori Nakagawa and Nozomi Yamaguchi. cAMP-Dependent Regulation of Spinesin/TMPRSS5 Gene Expression in Astrocytes. Journal of Neuroscience Research 2008; 86: 610-617.
3.100
Yang Shieh-Yueh, Jui-Sheng Sun, Cheng-Heng Liu, Yang-Hwei Tsuang, Li-Ting Chen, Chin-Yih Hong, Hong-Chang Yang, and Herng-Er Horng. Ex Vivo Magnetofection with Magnetic Nanoparticles: A Novel Platform for Nonviral Tissue Engineering. Artif Organs 2008; 32 (3):195-204.
3.101
Han S.J., Duong H.-Q., Choi J. E., Lee T.-B., Kim C. H., Lee S. Y., Jeon H. M., Shin S.-H., Lim S.-C. and Kang H. S. Hyperthermia switches glucose depletion-induced necrosis to apoptosis in A549 lung adenocarcinoma cells. INTERNATIONAL JOURNAL OF ONCOLOGY 2008; 32: 851-860.
3.102
Cho Li-La, Young-Mee Moon, Yu-Jung Heo, Yun-JuWoo, Ji-Hyeon Ju, Kyung-Su Park, Sung-Il Kim, Sung-Hwan Park, Ho-Youn Kim, Jun-Ki Min. NF-кB inhibition leads to increased synthesis and secretion of MIF in human CD4+ T cells. Immunology Letters 2009; 123: 21-30.
3.103
Egaňa L.A., Rolando A. Cuevas, Tracy B. Baust, Leonardo A. Parra, Rehana K. Leak, Sarah Hochendoner, Karina Peňa, Marisol Quiroz, Weimin C. Hong, Mario M. Dorostkar, Roger Janz, Harald H. Sitte and Gonzalo E. Torres. Physical and Functional Interaction between the Dopamine Transporter and the Synaptic Vesicle Protein Synaptogyrin-3. The Journal of Neuroscience 2009; 29(14): 4592-4604.
3.104
Fiorentino H., Nicola Kuczewski, Diabe Diabira, Nadine Ferrand, Menelas N. Pangalos, Christophe Porcher and Jean-Luc Gaiarsa. GABAB Receptor Activation Triggers BDNF Release and Promotes the Maturation of GABAergic Synapses. The Journal of Neuroscience 2009; 29(37): 11650-11661.
3.105
Ivanov A., Monique Esclapez, Christophe Pellegrino, Tomoaki Shirao and Lotfi Ferhat. Drebrin A regulates dendritic spine plasticity and synaptic function in mature cultured hippocampal neurons. Journal of Cell Science 2009; 122: 524-534.
3.106
Kenny S., Cedric Duval, Stephen J. Sammut, Islay Steele, D. Mark Pritchard, John C.Atherton, Richard H. Argent, Rod Dimaline, Graham J. Dockray and Andrea Varro. Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2009; Article in press.
3.107
Megias J., Maria Isabel Guillen, Victoria Clerigues, Ana I. Rojo, Antonio Cuadrado, Miguel Angel Castejon, Francisco Gomar, Maria Jose Alcaraz. Heme oxygenase-1 induction modulates microsomal prostaglandin E synthase-1 expression and prostaglandin E2 production in osteoarthritic chondrocytes. Biochemical Pharmacology 2009; 77: 1806-1813.
3.108
Tanaka M., Yoshihisa Watanabe and Kanji Yoshimoto. Regulation of Relaxin 3 Gene Expression Via cAMP-PKA in a Neuroblastoma Cell Line. Journal of Neuroscience Research 2009; 87: 820-829.
3.109
Svingen T., Wilhelm D., Combes A. N., Hosking B., Harley V. R., Sinclair A. H. and Koopman P. Ex Vivo Magnetofection: A Novel Strategy for the Study of Gene Function in Mouse Organogenesis. DEVELOPMENTAL DYNAMICS 2009; 238:956-964.
3.110
Vieyres G., Allan G.N. Angus, Anita Haberstroh, Thomas F. Baumert, Jean Dubuisson, Arvind H. Patel Rapid synchronization of hepatitis C virus infection by magnetic adsorption Journal of Virological Methods 2009; 157: 69-79.
3.111
Wong J. and Cynthia Shannon Weickert Transcriptional Interaction of an Estrogen Receptor Splice Variant and ErbB4 Suggests Convergence in Gene Susceptibility Pathways in Schizophrenia THE JOURNAL OF BIOLOGICAL CHEMISTRY 2009; 284(28):18824-18832
3.112
Yiu H.P., Stuart C. McBain, Zoe A. D. Lethbridge, Martin R. Lees, Jon Dobson. Preparation and characterization of polyethylenimine-coated Fe3O4-MCM-48 nanocomposite particles as a novel agent for magnet-assisted transfection. Journal of Biomedical Materials Research Part A 2009; 386-392.
3.113
Hofmann A., Wenzel D., Becher U.M., Freitag D.F., Klein A. M., Eberbeck D., Schulte M., Zimmermann K., Bergemann C., Gleich B., Roell W., Weyh T., Trahms L., Nickenig G., Fleischmann B. K. and Pfeifer A. Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles. PNAS 2009; 106 (1): 44-49.
3.114
Hofmann et al. Supporting Information. 10.1073/pnas.0803746106, PNAS 2009: 1-9
3.115
Saeki Yuko, Takaho Endo, Kaori Ide, Takeshi Nagashima, Noriko Yumoto, Tetsuro Toyoda, Harukazu Suzuki, Yoshihide Hayashizaki, Yoshiyuki Sakaki and Mariko Okada-Hatakeyama. Ligand-specific sequential regulation of transcription factors for differentiation of MCF-7 cells. BMC Genomics 2009; 10: 545.

References - Magnetic Drug Targeting

4.01
Lübbe A.S., Bergemann C. et al. Preclinical Experiences with Magnetic Drug Targeting: Tolerance and Efficacy. Cancer Research 1996; 56: 4694-4701.
4.02
Lübbe A.S. and Bergemann C. Selected Preclinical and First Clinical Experiences with Magnetically Targeted 4'-Epidoxorubicin in Patients with Advanced Solid Tumors. In: Häfeli et al. (Eds.), Scientific and Clinical Applications of Magnetic Carriers, Plenum Press, New York, 1997.
4.03
Lübbe A.S., Bergemann C. et al. Clinical Experiences with Magnetic Drug Targeting: A Phase I Study with 4'-Epidoxorubicin in 14 Patiens with Advanced Solid Tumors. Cancer Research 1996; 56: 4686-4693.
4.04
Lübbe A.S. and Bergemann C. Editorial Magnetically-controlled drug targeting. The Cancer J. 1998; 11: n° 3.
4.05
Lübbe A.S., Bergemann C., Brock J., McClure D.G. Physiological aspects in magnetic drug targeting. J. of Magnetism and Magnetic Materials 1999; 194: 149-155.
4.06
Lübbe A.S., Bergemann C. and Alexiou C. Magnetically-controlled Drug Targeting for cancer treatment. Recent Res. Devel. Cancer 2000; 2: 183-191.
4.07
Alexiou C., Arnold W., Klein R.J., Parak F.G., Hulin P., Bergemann C., Erhardt W., Wagenpfeil S., Lübbe A.S. Locoregional Cancer Treatment with Magnetic Drug Targeting. Cancer Research 2000; 60: 6641-6648.
4.08
Alexiou C., Arnold W., Hulin P., Klein R.J., Renz H., Parak F.G., Bergemann C., Lübbe A.S. Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting. J. of Magnetism and Magnetic Materials 2001; 225: 187-193.
4.09
Alexiou C., Arnold W., Hulin P., Klein R., Schmidt A., Bergemann C., Parak F.G. Therapeutic Efficacy of Ferrofluid Bound Anticancer Agent. Magnetohydrodynamics 2001; 37: 318-322.
4.10
Babincova M., Babinec P. and Bergemann C. High-Gradient Magnetic Capture of Ferrofluids: Implications for Drug Targeting and Tumor Embolization. Z. Naturforsch. 2001; 56c: 909-911.
4.11
Hilger I., Andrä W., Hiergeist R., Hergt R., Schubert H., Kaiser W. A. Electromagnetic Heating of Breast Tumors in Interventional Radiology: In Vitro and in Vivo Studies in Human Cadavers and Mice. Radiology 2001; 218: 570-575.
4.12
Lübbe A.S., M.D., Ph.D., Alexiou C. and Bergemann C. Clinical Applications of Magnetic Drug Targeting. J. of Surgical Res. 2001; 95: 200-206.
4.13
Lübbe A.S., Bergemann C. and Alexiou C. Targeting Tumors with Magnetic Drugs, in: M. Pagé (Eds.), Cancer Drug Discovery and Development: Tumor Targeting in Cancer Therapy. Humana Press Inc. Totowa, New York, 2002.
4.14
Hilger I., Frühauf K., Andrä W., Hiergeist R., Hergt R., Kaiser W. A. Heating Potential of Iron Oxides for Therapeutic Purposes in Interventional Radiology. Acad Radiol 2002; 9: 198-202.
4.15
Flores G. A. & Liu J. In-vitro Blockage of a Simulated Vascular System Using Magnetorheological Fluids as a Cancer Therapy. European Cells and Materials 2002; 3(2): 9-11.
4.16
Alexiou C., Schmid R., Jurgons R., Bergemann C., Arnold W., Parak F.G. Targeting Tumor Therapy with Magnetic Drug Targeting: Therapeutic Efficacy of Ferrofluid Bound Mitoxantrone, in: S. Odenbach (Eds.), Ferrofluids: Magnetically Controllable Fluids and Their Applications. Springer Verlag, Berlin, 2002.
4.17
Alexiou C., Schmidt A., Klein R., Hulin P., Bergemann C., Arnold W. Magnetic drug targeting: biodistribution and dependency om magnetic field strength. J. of Magnetism and Magnetic Materials 2002; 252: 363-366.
4.18
Alexiou C., Jurgons R., Schmid R. J., Bergemann C., Henke J., Erhardt W., Huenges E. and Parak F. Magnetic Drug Targeting-Biodistribution of the Magnetic Carrier and the Chemotherapeutic agent Mitoxantrone after Locoregional Cancer Treatment. J. Drug Targeting 2003; 11(3): 139-149.
4.19
Babincova M., Altanerova V., Altaner C., Cicmanec P. and Babinec P. In vivo heating of magnetic nanoparticles in alternating magnetic field. Med. Phys. 2004; 31 (8): 2219-2221.
4.20
Lemke A.-J., Senfft von Pilsach M.-I., Lübbe A., Bergemann C. et al. MRI after magnetic drug targeting in patients with advanced solid malignant tumors. Eur. Radiology 2004; 14: 1949-1955.
4.21
Alexiou C., Jurgons R., Schmid R., Hilpert A., Bergemann C., Parak F. and Iro H. In vitro and in vivo investigations of targeted chemotherapy with magnetic nanoparticles. J. of Magnetism and Magnetic Materials 2005; 293: 389-393.
4.22
Alexiou C. et al. Targeting cancer cells: magnetic nanoparticles as drug carriers. Eur. Biophys J. 2006; 35: 446-450.
4.23
Steinfeld U., Pauli Ch., Kaltz N., Bergemann Ch. and Lee Hyeck-Hee. T-lymphocytes as potential therapeutic drug carrier for cancer treatment. Int. J. of Pharmaceutics 2006; 311: 229-236.
4.24
Alexiou Ch., Dirk Diehl, Peter Henninger, Heinrich Iro, Rudolf Röckelein, Wolfgang Schmidt and Horst Weber. A High Field Gradient Magnet for Magnetic Drug Targeting. IEEE TRANSACTIONS ON APPLIED SUPERCONDUCTIVITY 2006; 16(2): 1527-1530.
4.25
Shapiro B., Probst R., Potts H.E., Diver D.A. and Lübbe A.S. Control to Concentrate Drug-Coated Magnetic Particles to Deep-Tissue Tumors for Targeted Cancer Chemotherapy. in press 2007
4.26
Dandamudi S. and Campbell R.B. The drug loading, cytotoxicity and tumor vascular targeting characteristics of magnetite in magnetic drug targeting. Biomaterials 2007; 28 (31): 4673-4683.
4.27
Dames P., Gleich B., Flemmer A., Hajek K., Seidl N., Wiekhorst F., Eberbeck D., Bittmann I., Bergemann Ch., Weyh T., Trahms L., Rosenecker J. and Rudolph C. Targeted delivery of magnetic aerosol droplets to the lung. Nature Nanotechnology August 2007; 2 (8): 495-499.
4.28
Chertok B., Allan E. David, Yongzhuo Huang and Victor C. Yang. Glioma Selectivity of Magnetically Targeted Nanoparticles: A Role of Abnormal Tumor Hydrodynamics. J Control Release. 2007 October 8; 122(3): 315–323.
4.29
Babincova M., Altanerova V., Altaner C., Bergemann C. and Babinec P. In Vitro Analysis of Cisplatin Functionalized Magnetic Nanoparticles in Combined Cancer Chemotherapy and Electromagnetic Hyperthermia. IEEE Transactions on Nanobioscience, 2008; 7(1): 15-19.
4.30
McGill S. L., Carla L. Cuylear, Natalie L. Adolphi, Marek Osinski and Hugh D. C. Smyth Magnetically Responsive Nanoparticles for Drug Delivery Applications Using Low Magnetic Field Strengths IEEE Transactions on Biosciences March 2009; 8 (1): 33 – 42.
4.31
Kallumadil M., Masaru Tada, Takashi Nakagawa, Masanori Abe, Paul Southern, Quentin A. Pankhurst Suitability of commercial colloids for magnetic hyperthermia. Journal of Magnetism and Magnetic Materials 2009; 321: 1509-1513.
4.32
Kettering M., Heike Zorn, Sibylle Bremer-Streck, Hartmut Oehring, Matthias Zeisberger, Christian Bergemann, Rudolf Hergt, Karl-Jürgen Halbhuber, Werner A Kaiser and Ingrid Hilger Characterization of iron oxide nanoparticles adsorbed with cisplatin for biomedical applications. Phys. Med. Biol. 2009; 54: 5109-5121.
4.33
Wiegand S., Thomas Heinen, Annette Ramaswamy, Andreas M. Sesterhenn, Christian Bergemann, Jochen A. Werner, Andreas S. Lübbe Evaluation of the tolerance and distribution of intravenously applied ferrofluid particles of 250 and 500 nm size in an animal model. Journal of Drug Targeting 2009;17(3): page 1.
4.34
Chertok B., Allan E. David, Bradford A. Moffat, Victor C. Yang. Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking. Biomaterials 2009; XXX: 1–8. in press.